香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 的 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部 或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 NANJING SINOLIFE UNITED COMPANY LIMITED* 南 京 中 生 聯 合 股 份 有 限 公 司 南京中生聯合股份有限公司 董事長 桂平湖 中華人民共和國，南京，二零二五年八月十二日 於本公告日期，本公司執行董事為桂平湖先生、張源女士及朱飛飛女士；以及本 公司獨立非執行董事為余波先生、葉邦銀先生及程建明先生。 * 僅供識別 （於中華人民共和國註冊成立的股份有限公司） （股份代號：3332） 董事會會議召開日期 南京中生聯合股份有限公司（「本公司」）董事會（「董事會」）兹通告謹定於二零二五 年八月二十二日（ 星期五 ）舉行董事會會議，以考慮及通過本公司及其附屬公司截 至二零二五年六月三十日止的六個月中期業績，及派發中期股息（ 如有 ），以及處 理其他事項。 承董事會命 ...

截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 南京中生聯合股份有限公司 呈交日期: 2025年8月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 03332 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 946,298,370 | RMB | | 0.1 RMB | | 94,629,837 | | 增加 / 減少 (-) | | | 0 | | | RMB | | | | 本月底結存 | | | 946,298,370 | RMB | | 0.1 RMB | | 94,629,837 | 本月底法定/註冊股本總額： RMB 94,629,837 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 FF3 ...

Core Viewpoint - The company expects a significant decrease in net profit for the six months ending June 30, 2025, compared to the same period in 2024, primarily due to declining sales in the domestic distributor platform for baby products and increased promotional expenses on e-commerce platforms [1] Summary by Relevant Categories Financial Performance - The company anticipates a net profit of approximately RMB 12 million to RMB 18 million for the six months ending June 30, 2025, compared to a net profit of approximately RMB 33.4 million for the same period in 2024 [1] Sales and Revenue - The decline in net profit is attributed to a decrease in sales revenue from the domestic distributor platform for baby products [1] - Increased promotional expenses on e-commerce platforms are also impacting the company's financial performance [1]

Core Viewpoint - The company expects a significant decrease in net profit for the six months ending June 30, 2025, compared to the previous period, primarily due to declining sales and increased promotional expenses [1] Financial Performance - The projected net profit for the six months ending June 30, 2025, is estimated to be between RMB 12 million and RMB 18 million [1] - In contrast, the net profit for the six months ending June 30, 2024, was approximately RMB 33.4 million, indicating a substantial decline [1] Factors Influencing Performance - The decrease in net profit is attributed to two main factors: 1. A decline in sales revenue from the domestic distributor platform for baby and child products [1] 2. An increase in promotional expenses on e-commerce platforms [1]

Group 1 - The company expects to record a net profit of approximately RMB 12 million to RMB 18 million for the six months ending June 30, 2025, compared to a net profit of approximately RMB 33.4 million for the six months ending June 30, 2024 [1] - The decrease in net profit is primarily attributed to a decline in sales revenue from the domestic distributor platform for infant and child products [1] - Increased promotional expenses on e-commerce platforms have also contributed to the reduction in net profit [1]

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 的 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部 或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 NANJING SINOLIFE UNITED COMPANY LIMITED* 南 京 中 生 聯 合 股 份 有 限 公 司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：3332） 盈利警告 本 公 告 乃 由 南 京 中 生 聯 合 股 份 有 限 公 司（「 本 公 司 」， 連 同 其 附 屬 公 司 統 稱「 本 集 團」）根據香港聯合交易所有限公司證券上市規則（「上市規則」）第13.09條及香港法 例第571章證券及期貨條例第XIVA部之內幕消息條文（ 定義見上市規則 ）刊發。 * 僅供識別 – 1 – 潛在投資者及股東在買賣本公司證券時務請審慎行事。 承董事會命 南京中生聯合股份有限公司 桂平湖 董事長 中華人民共和國，南京，2025年7月30日 本公司董事會（「董事會」）謹此知會本公司股東（「股東」）及潛在投 ...

Group 1 - The A-share IP concept sector is experiencing a surge in popularity, with stocks like Aoya Co., Ltd. and Deyi Cultural Creativity reaching their daily limit up [1] - Bubble Mart's stock price continues to rise, reaching 277.6 HKD per share, with a market capitalization exceeding 370 billion HKD and a year-to-date increase of over 200% [1] - Suzhou Longjie has seen its stock price hit a daily limit for three consecutive days, reaching 21.54 CNY per share, with a total market value of 4.646 billion CNY [1] Group 2 - Suzhou Longjie's products include differentiated polyester filament and PTT fiber, primarily used in civilian textiles, with a projected revenue of 1.259 billion CNY in 2024, reflecting a year-on-year growth of 15.22% [3] - The net profit for Suzhou Longjie is expected to reach 58.14 million CNY in 2024, a significant increase of 520.05% year-on-year [3] - However, the company's performance in Q1 2025 showed a substantial decline, with a non-recurring net profit of only 680,000 CNY, down 93.01% year-on-year, indicating potential uncertainties in its development [3] Group 3 - The IP economy is currently experiencing explosive growth, with top IPs generating significant value across various sectors, including film, toys, and cultural products [3] - Bubble Mart's IP Labubu has seen sales reach 3.04 billion CNY in 2024, a year-on-year increase of over 700%, contributing to the company's stock price surge [4] - The Labubu series is in high demand globally, with products in the European and American markets selling at a premium of over seven times [5] Group 4 - Companies are increasingly collaborating with popular IPs to leverage their popularity for business expansion and performance growth, leading to a market frenzy for related concept stocks [5] - Long-term development for Suzhou Longjie relies on technological innovation and business expansion, with potential for performance growth if it successfully enters the IP derivative supply chain [5]

Summary of Key Points Core Viewpoint - As of May 6, a total of 55 stocks reached their 52-week highs, with notable performers including Shandong Molong (00568), Tokyo Central Auction (01939), and Andeli Juice (02218) showing significant increases in their high rates [1]. 52-Week Highs - Shandong Molong (00568) achieved a closing price of 5.020 with a peak of 5.250, marking a high rate of 185.33% - Tokyo Central Auction (01939) closed at 0.980, reaching a high of 3.180, resulting in a high rate of 112.00% - Andeli Juice (02218) closed at 16.000 with a peak of 23.950, reflecting a high rate of 87.11% - Other notable stocks include: - Crown Holdings (01872) with a high rate of 32.00% - Wutong International (00613) at 30.00% - Yao Cai Securities Financial (01428) at 10.47% [1]. 52-Week Lows - Madison Holdings (08057) recorded a closing price of 0.053, with a low of 0.050, reflecting a decline of 26.47% - China Classic Group (08281) closed at 0.060, reaching a low of 0.051, indicating a drop of 15.00% - Other companies experiencing significant declines include: - Zhongsheng United (03332) with a decline of 6.02% - Dingyi Group Investment (00508) at -5.88% - Derivative Group (06893) at -4.62% [2].

Financial Performance - Revenue increased by approximately 32.6% to RMB747.9 million (2023: RMB564.0 million) [21] - Gross profit increased by approximately 41.8% to RMB538.3 million (2023: RMB379.7 million) [21] - Profit for the Year was RMB34.6 million (2023: Profit of RMB52.6 million) [21] - Profit per share was RMB3.65 cents (2023: Profit per share RMB5.56 cents) [21] - The Group recorded a profit of approximately RMB 34.6 million for 2024, a decrease of approximately RMB 18.0 million from a profit of approximately RMB 52.6 million in 2023[46] - The gross profit increased by approximately 41.8% from approximately RMB 379.7 million in 2023 to approximately RMB 538.3 million in 2024, with a gross profit margin rising from 67.3% to 72.0%[53][57] - The Group recorded a foreign exchange loss of approximately RMB 18.5 million in 2024, compared to a gain of approximately RMB 1.7 million in 2023[63] - The effective tax rate increased from 9.5% in 2023 to 15.4% in 2024, primarily due to increased profits from one of the Group's subsidiaries[61][66] - The Group reported accumulated losses of RMB 284.5 million as of December 31, 2024[172] Dividends - The Board does not recommend the payment of any final dividend or special dividend for the Year (2023: Nil) [21] - The Group did not declare any final or special dividends for the year ended December 31, 2024[163] Market Strategy and Growth - The Company plans to expand its market presence and invest in new product development [22] - The Company is focusing on strategic acquisitions to enhance its competitive position [22] - The management anticipates continued growth in revenue and profitability in the upcoming fiscal year [22] - The focus on cross-border e-commerce for nutritional supplements under the Good Health brand contributed to rapid business growth[46] - The Group aims to achieve the goal of being the top seller in core product categories on e-commerce platforms[35] - The Group will expand its health products in multiple sales channels in the PRC, New Zealand, and Australia[32] - The Chinese consumer healthcare industry is experiencing high-quality and rapid development, driven by increasing health awareness among the large population[28] - The demand for high-quality imported healthcare products is growing, supported by the development of cross-border e-commerce platforms[28] - The younger generation's focus on appearance and healthy lifestyles is shifting market demand towards innovation and sustainability[31] Expenses and Cost Management - Selling and distribution expenses increased by approximately 63.4% from approximately RMB 250.0 million in 2023 to approximately RMB 408.6 million in 2024, representing 44.3% and 54.6% of the Group's revenue respectively[59][64] - Administrative expenses rose by approximately 22.7% from approximately RMB 72.2 million in 2023 to approximately RMB 88.6 million in 2024, accounting for 12.8% and 11.8% of revenue respectively[60][65] - The Group is committed to optimizing marketing and promotional expenses to improve overall profitability[35] Product Development - The Group launched a total of 26 new products in 2024, including 3 New Goodhealth series products and 22 Good Health series products[48][50] - The increase in revenue was primarily driven by significant growth in the Good Health brand's revenue from cross-border e-commerce platforms[52][56] - The nutritional supplements industry is characterized by rapid changes in demand for new products, necessitating constant innovation[89] Employee and Management Information - The Group employed 477 employees as of December 31, 2024, an increase from 349 employees as of December 31, 2023[90] - Total salaries and related costs for the year amounted to approximately RMB 120.8 million, up from approximately RMB 89.8 million in the previous year[90] - The Company has established various social security funds for its employees in the PRC, including pension and medical insurance[158] - The Company has appointed Mr. Ye Bangyin and Mr. Cheng Jianming as independent non-executive Directors effective from 23 October 2024[180] - Ms. Cai Tianchen and Mr. Wang Wei resigned as independent non-executive Directors effective from 22 October 2024 after serving for six years[180] Risk Factors - The Group faces risks related to the increase in prices of raw materials and packaging materials, which could adversely affect its business operations[82] - The Group is exposed to foreign currency risk primarily for purchases in USD, AUD, and NZD, which could significantly impact profitability due to fluctuations in exchange rates[89] - A depreciation of RMB could increase costs for purchasing products from Australia and New Zealand, requiring more RMB to obtain the equivalent foreign currency[89] - The Group has not used any derivative contracts to hedge against foreign currency risk, leaving it vulnerable to exchange rate fluctuations[89] - The success of new product offerings depends on accurately anticipating customer needs and timely commercialization[89] - Failure to introduce new products in a timely manner could lead to obsolescence and negatively affect operating results[89] - The Group's ability to maintain customer relationships and market share is contingent on its responsiveness to changing consumer preferences[89] Corporate Governance - The Company aims to ensure compliance with corporate governance practices as prescribed in the Listing Rules[145] - The Company has established four Board committees: Audit Committee, Remuneration Committee, Nomination Committee, and Strategy and Development Committee[145] - The Audit Committee assists the Board in reviewing financial information, risk management, and internal control systems[149] - The Remuneration Committee reviews and makes recommendations on the remuneration packages of individual Directors and senior management[150] - The Nomination Committee assesses the independence of independent non-executive Directors and makes recommendations on appointments[151] - The Strategy and Development Committee conducts research and submits proposals concerning long-term development strategies[152] Financial Position - Cash and cash equivalents decreased by approximately RMB 13.0 million during the year, with net cash inflow from operating activities of approximately RMB 1.0 million and net cash outflow from investing and financing activities of approximately RMB 6.0 million and RMB 4.5 million, respectively[69] - Inventories increased by approximately 9.4% to RMB 119.1 million as of December 31, 2024, compared to RMB 108.9 million in 2023, with inventory turnover days increasing by 15 days to approximately 196 days[70] - Trade receivables rose by approximately RMB 9.4 million or 28.9% to RMB 41.9 million as of December 31, 2024, driven by increased revenue from e-commerce channels[71] - Trade payables decreased by approximately RMB 20.3 million or 61.3% to RMB 12.8 million as of December 31, 2024, due to a reduction in raw material purchases[72] - The gearing ratio improved to approximately 18.7% as of December 31, 2024, down from 22.0% in 2023[79] - Capital expenditure for the year was approximately RMB 7.4 million, significantly higher than RMB 1.7 million in 2023, indicating increased investment in property, plant, and equipment[80] - The Group did not have any outstanding borrowings or pledges of assets as of December 31, 2024[78] - Revenue from the Group's five largest customers accounted for less than 30% of total revenue, with the largest customer contributing less than 10%[174]

Financial Performance - Revenue increased by approximately 32.6% to RMB 747.9 million (2023: RMB 564.0 million) [3] - Gross profit increased by approximately 41.8% to RMB 538.3 million (2023: RMB 379.7 million) [3] - Net profit for the year was RMB 34.6 million (2023: net profit RMB 52.6 million) [3] - Earnings per share for the year was RMB 3.65 (2023: earnings per share RMB 5.56) [3] - Total comprehensive income for the year amounted to RMB 16.0 million (2023: RMB 54.3 million) [4] - The company recorded a profit of approximately RMB 34.6 million in 2024, a decrease of approximately RMB 18.0 million from RMB 52.6 million in 2023 [43] Expenses and Costs - Selling and distribution expenses increased significantly to RMB 408.6 million (2023: RMB 250.0 million) [4] - Administrative expenses rose to RMB 88.6 million (2023: RMB 72.2 million) [4] - The group's operating profit before tax for 2024 was impacted by various costs, including cost of goods sold amounting to RMB 206,318,000, up from RMB 181,316,000 in 2023, which is an increase of about 13.8% [30] - The total tax expense for the year was RMB 6,320,000, compared to RMB 5,491,000 in 2023, representing an increase of approximately 15% [33] Assets and Liabilities - Total assets as of December 31, 2024, amounted to RMB 505,419,000, while total assets for 2023 were RMB 505,557,000, indicating a slight decrease of 0.03% [5] - The total value of non-current assets increased from RMB 218,226,000 in 2023 to RMB 229,905,000 in 2024, reflecting a growth of approximately 5.5% [5] - Current assets totaled RMB 275,514,000 in 2024, compared to RMB 287,331,000 in 2023, showing a decline of about 4.1% [5] - The net value of current liabilities decreased from RMB 82,051,000 in 2023 to RMB 69,139,000 in 2024, representing a reduction of approximately 15.7% [6] - The total equity attributable to the parent company increased from RMB 378,069,000 in 2023 to RMB 394,096,000 in 2024, marking an increase of about 4.2% [6] - The company reported a decrease in non-current liabilities from RMB 45,299,000 in 2023 to RMB 42,322,000 in 2024, which is a decline of approximately 6.5% [6] - The company’s total liabilities decreased from RMB 436,418,000 in 2023 to RMB 423,368,000 in 2024, showing a reduction of about 3% [6] Cash Flow and Investments - Cash and cash equivalents increased from RMB 104,530,000 in 2023 to RMB 117,556,000 in 2024, indicating a growth of about 12.5% [5] - The group invested approximately RMB 7.4 million in capital expenditures during the year, compared to RMB 1.7 million in 2023 [61] Market and Operations - The company operates primarily in China, Australia, and New Zealand, focusing on the manufacturing and sales of nutritional dietary supplements and health foods [8] - The group operates a single reportable segment focused on manufacturing and selling nutritional supplements and packaged health foods in China, Australia, and New Zealand [23] - Revenue from the Chinese market was RMB 623,538,000 in 2024, up from RMB 432,391,000 in 2023, representing a growth of 44.2% [25] - Revenue from New Zealand decreased to RMB 100,103,000 in 2024 from RMB 113,712,000 in 2023, a decline of 11.3% [25] - Revenue from Australia increased to RMB 8,411,000 in 2024 from RMB 4,701,000 in 2023, showing a growth of 78.0% [25] Financial Reporting Standards - The company has not experienced any impact on its financial position or performance due to the amendments to the Hong Kong Financial Reporting Standards since the initial application date [11] - The amendments clarify the classification of liabilities as current or non-current, ensuring that the classification remains unchanged after the initial application of the amendments [12] - The company does not have any supplier financing arrangements, thus the amendments regarding supplier financing do not impact its financial statements [12] - The group has confirmed that there are no variable lease payments affecting its financial situation [11] - The amendments are expected to have no significant impact on the company's financial statements [18] Corporate Governance - The company has adopted the corporate governance code and has complied with all applicable principles and provisions during the year [71] - The audit committee has been established and is responsible for reviewing and supervising financial reporting procedures and risk management [72] - The financial statements for the year have been reviewed and confirmed by Ernst & Young, ensuring consistency with the group's audited financial results [73] Future Outlook - The group plans to focus on developing cross-border e-commerce and optimizing promotional strategies for its e-commerce platform in 2024 [64] - The group anticipates further growth in e-commerce revenue due to the expansion of its e-commerce channels [56] - The company aims to achieve the goal of being the top seller in its e-commerce platform's core product category [69] - The company plans to enhance supply chain management by developing quality suppliers and improving production capacity to meet customer demand [69]